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Abstract 
 The impact of operator and centre volume on clinical outcomes and quality of care 
has been of considerable debate in recent years in a number of surgical and procedural based 
specialities. A relationship between higher volumes at both the institutional and operator 
level and better clinical outcomes would at first appear intuitive, based on the premise that 
performing a procedure very infrequently would be likely to lead to unfamiliarity, 
complications and poorer outcomes. In the current review, we study the relationship between 
operator volume and outcomes in the setting of percutaneous coronary intervention (PCI), 
and examine the evidence for current clinical competency guidelines that advocate that a 
minimum number of PCI procedures be undertaken annually. Whilst both high institutional 
and operator volumes have been shown to be associated with better outcomes by reducing 
death and in-hospital mortality, this data is often derived from the pre-stent era, or when high 
volume operators undertook far smaller numbers of procedures than is currently 
recommended to maintain clinical competency. The emphasis of specific volume 
requirements for optimal outcomes need to be interpreted with caution, as volume is not a 
surrogate for quality and merely one of the variables associated with outcome. Health care 
providers should focus on other measures of quality such as robust clinical care pathways, 
evidence based treatments, periodic case review, using validated risk assessment scores and 
ascertainment of outcome to improve care and reduce adverse events.   
 
Introduction 
 The impact of operator and centre volume on clinical outcomes and quality of care 
has been of considerable debate in recent years in a number of surgical and procedural based 
specialities. In the setting of percutaneous coronary intervention (PCI) this has been driven in 
part, by the expansion of both the number of institutions and of individual operators 
undertaking such procedures and secondly by the decline in the total number of PCI 
procedures performed in certain countries 1. This has been reflected in a decline in procedural 
volumes at both the operator- and institutional-level.  
 A relationship between higher volumes at both the institutional and operator level and 
better clinical outcomes would at first appear to be intuitive, based on the premise that 
performing a procedure very infrequently would be likely to lead to unfamiliarity, 
complications and poorer outcomes. Previous studies have suggested that low operator/ 
institutional volume may be associated with an increased risk of adverse events in the PCI 
setting 2-4. Current American College of Cardiology, American Heart Association and Society 
for Cardiovascular Angiography and Intervention (ACC/AHA/SCAI) clinical competency 
guidelines recommend minimum requirement of 50 interventional procedures per year 
(averaged over two years) to maintain competency to perform PCI 5 with class C level of 
evidence, reduced from previous older recommendations derived from the same professional 
bodies of 75 procedures per year 6. In the UK, the British Cardiovascular Interventional 
Society (BCIS) advocates that independent operator should perform a total of 150 procedures 
over two years to maintain competency 7 with similar recommendations from the ESC 
guidelines giving a class IIa evidence level C recommendation for individuals undertaking 
PCI for acute coronary syndromes 8.  
 In this review we sought to assess the evidence behind such recommendations and the 
association between operator volume and clinical outcomes in the setting of PCI.  
 
Operator volume relationship with major outcomes:  
 Traditionally the benchmark outcomes used to define successful PCI are mortality (in-
hospital and 30 days), unplanned CABG (same day, same stay, urgent or elective), 
neurological events such as stroke, TIA, myocardial infarction and major contrast reactions.  
 A number of studies have reported the association of volume with mortality in PCI 
and CABG 9-11. For instance, Hannan et al. investigated the mortality in different volume 
operators for CABG and found that high volume surgeons have lower risk-adjusted mortality 
rates 12. Various observational studies have also reported variable volume-mortality 
relationships in PCI setting 3, 13-17 with studies showing both an association with increased 
operator volumes and better outcomes 13, 18, 19 and no effect 14, 16, 20, 21. Table 1 represents an 
overview of key studies investigating the association between operator volumes and clinical 
outcomes. 
 An analysis of 457,498 PCI procedures performed in the United States between 2005 
and 2009 illustrated that crude mortality rates decreased with increasing annual operator 
volume, with crude mortality rates of 1.68%, 1.15%, 0.87%, and 0.59% in 1st (≤15 PCIs/yr), 
2nd (16–44 PCIs/yr), 3rd (45–100 PCIs/yr), and 4th (>100 PCIs/yr) quartiles of operator 
volume 19. Following adjustment for differences in baseline co-variates, patients treated by 
lowest quartile of operator volume, OR of mortality for the patients treated by 2nd, 3rd, and 
4th quartile of operator volume were 0.80 (0.74–0.87, P<0.001), 0.81(0.74–0.89, P<0.001), 
and 0.65(0.58–0.73, P<0.001), respectively. Interestingly, the authors of this study report a 
cut-off, whereby further increases in operator volume do not reduce predicted mortality, with 
predicted probability of mortality decreased with increasing operator volume but flattening at 
≈300 procedures per year. Minges et al. studied hospital mortality in 3649 physicians who 
performed 345,526 PCIs. After multivariable adjustment, in-hospital mortality was 
significantly higher among physicians performing <75 PCIs/year (OR=1.14; 95% CI: 1.05 to 
1.24). However the absolute difference in mortality was only 0.3%.  Moscucci et al. 13 
undertook a study of 18,504 consecutive PCIs performed by 165 operators in a regional 
registry based in Detroit, and reported that the unadjusted major adverse cardiovascular event 
(MACE) rate was significantly higher in the group of patients treated by lowest volume 
operators (Quartile 1 and 2) when compared with the group of patients treated by highest 
volume operators (Quartile 5) (7.38% and 6.13% vs. 4.15%, p = 0.002 and p < 0.0001, which 
persisted after adjustment for differences in baseline co-variates (adjusted OR 1.63, 95% CI 
1.29 to 2.06, p < 0.0001 for Q1 vs. Q5; adjusted OR 1.63, 95% CI 1.34 to 1.90, p < 0.0001 
for Q2 vs. Q5). Interestingly, no relationship between in-hospital mortality and operator 
volume was documented in this cohort of patients once differences in baseline covariates 
were adjusted for. When operators where stratified according to whether they met the 75 case 
annual operator volume recommendations made by the ACC/AHA at the time of publication 
of the paper, MACCE and mortality were risks were similar in patients treated by operators 
performing <75 PCI/year when compared with the group of patients treated by operators 
performing ≥75 PCI/year (adjusted OR for death 0.81, 95% CI 0.47 to 1.41, p = 0.46; 
adjusted OR for MACE 1.05, 95% CI 0.83 to 1.32, p = 0.67) 13.  
 A recent meta-analysis of 23 studies evaluating 15,907 operators performing 205,214 
PCIs that predated the largest analysis to date by Badheka et al. 19, illustrated that operator 
volume was not related to mortality (OR 0.96 95% CI 0.86-1.08), although they reported a 
decrease in MACCE comparing high- with low-volume operators with an odds ratio of 0.62 
(95% CI, 0.4–0.97) 22. A limitation of this meta-analysis was that the definitions of high and 
low volume operators varied across studies, with studies comparing outcomes between 
operators undertaking ≥11 PCI procedures to those undertaking 1-2 annually 18 and those 
comparing outcomes of operators undertaking ≥100 procedures annually with those <100 
procedures 21 pooled, resulting in significant heterogeneity.  
 The variable relationships reported between operator volumes and outcomes in PCI 
may relate to a number of factors. Studies have not adjusted for differences in patient co-
variates 23 or failed to adjust for time trends that may influence outcomes independently of 
operator volumes 3, 11, 20, 24. Most studies have not adjusted for hospital volumes and much of 
the available evidence stems from the pre-stent era of PCI. Furthermore, even in the largest, 
most contemporary analysis to date by Badheka et al. 19, data relating to procedural and 
lesion characteristics were not available and half the PCIs undertaken during this period 
where excluded due to missing unique operator identification numbers which will have 
potentially introduced significant bias. In three of the most contemporary / largest studies that 
have focussed on operator volume outcomes 13, 17, 19 case-mix adjustment has been performed 
through inclusion of potential confounding factors in regression models. It is important to 
distinguish between confounders and mediators: it is not appropriate to correct analyses for 
procedural decision variables, as these may be consequences of the experience of the operator 
or centre; all studies considered appropriately did not consider such variables. All studies also 
accounted appropriately for clustering at the centre level – through inclusion of random 
effects 13, 19 or generalised estimating equations 17. There are some limitations in the 
approaches used in existing studies. One is that volume is either dichotomised or categorised, 
rather than considering volume as a continuous variable and allowing non-linear effects 
(Badheka et al 19 do consider splines, but only in their univariable modelling not 
multivariable modelling). A second limitation is in the definition of volume itself, which is 
taken is the number of procedures performed in the current calendar year. Therefore, 
procedures performed early in a year have outcomes that are predicted based on future 
volume. An alternative would be to define volume on a procedure-by-procedure basis, as the 
number of procedures performed over the previous 12 months. Finally, a common problem in 
the existing analyses is that the highest volume category reported tends to underestimate the 
actual procedure volumes, since that category is open ended and its reference point is the 
lowest volume in the range. This can be particularly problematic when these data are used to 
estimate volume thresholds that are being recommended to achieve desired outcomes. 
 
Operator volume and its association with outcomes in Primary Percutaneous coronary 
intervention (PPCI) 
 PPCI is considered the current gold standard reperfusion therapy in patients 
presenting with ST-elevation myocardial infarction (STEMI). A number of studies have 
examined the relationship between PPCI interventionist annual volume and adverse outcomes 
18, 23, 25. Two studies 18, 25 have shown showed significant impact of operator volume on in-
hospital mortality, although these should be interpreted with caution as they analysed data 
from the mid 1990’s and 2000-2002, with high volume operators defined as having 
performed ≥ 11 procedures annually 18 or ≥ 10 procedures annually 25. Conversely, a third 
study based on a single centre containing 3 operators observed no relationship between 
operator volume and outcome 23. Interestingly, the study of Srinivas 25 examined PPCI 
outcomes in New York State examined the capacity of high-volume physicians to offset the 
risks of low-volume hospitals and vice versa by modelling their interactions. The estimated 
OR for operator volume categories stratified by low- and high-volume hospitals demonstrated 
no significant difference in outcome between high- and low-volume physicians (≥10/year vs. 
<10/year) in hospitals performing < 50 primary PCIs/year (OR: 1.44; 95% CI: 0.68 to 3.03). 
However, in hospitals performing ≥50 primary PCIs/year, high-volume physicians had 
significantly lower risk-adjusted mortality compared with low operator volume physicians 
(OR: 0.58; 95% CI: 0.39 to 0.86), suggesting an interaction between operator volume and 
institutional volumes and outcomes. A number of limitations exist when attempting to 
interpret data from such studies with currently measured metrics of system-wide quality, such 
as door-to-balloon time, unavailable to the authors 25; hence, the extent to which volume-
related differences in outcome were confounded by delays in treatment and other processes of 
care is unclear. 
 Further work is needed to unpack the relationship between volumes and outcomes in 
the context of PPCI. However, in light of the existing evidence, the AHA has recommended 
that operators should perform a minimum of 11 PPCI per year to maintain competency 5. 
BCIS on the other hand has recommended that operators participating in PPCI cases should 
undertake an absolute minimum of >50 elective/emergency cases/annum within the 
emergency PPCI site and a total workload of at least 120 PCI cases plus up to 30 
interventional diagnostic procedures 7.  
 
PCI volume and outcomes in different settings. 
 Procedural aspects of PCI and their success may also relate to volumes of procedure 
undertaken. For example, data derived from the RIVAL (RadIal Vs. femorAL) trial, that 
randomized 7,021 patients with acute coronary syndromes (ACS) to radial versus femoral 
access for PCI, suggests that procedural radial volumes may impact on PCI outcomes 
associated with the TRA utilisation 26. Whilst in the subgroup of high-volume radial centers 
the primary outcome was reduced by adoption of TRA, this was not observed in 
intermediate- or low-volume radial centers and furthermore there was no significant 
interaction by individual operator radial volume. In an analysis of the (National 
Cardiovascular data registry) NCDR, there was a clear relationship between volume of 
chronic total occlusion PCI cases and outcomes, with procedural success among operators 
performing <5, 5 to 10, and >10 CTO PCI procedures per year was 53%, 62%, and 75%, 
respectively (p <0.001) although MACE rates were similar 27. 
 Influence of institutional volume on outcomes: 
 In one of the very early studies relating institutional volume with outcomes, Hartz et 
al. 28 reported a neutral effect of institutional volume on adverse outcomes. Since then 
numerous other studies 20, 29 evaluated the relationship between centre volume and adverse 
outcomes, with several 29-31 reporting that there is an inverse relation between volume and 
outcomes, with the study by Badheka et al. suggesting that the relationship between centre 
volume and in-hospital mortality flattened in centres with an institutional volume >1500 
procedures a year 19. Interestingly this study suggested that the relationship between centre 
volume and outcomes became statistically non-significant once operator volume was added 
to the model 19. Similarly, the hospital volume effect was no longer evident once adjustments 
were made for other confounding risk factors.  
 Reported associations between centre volume and clinical outcomes may only apply 
to higher risk cases. In an analysis of outcomes derived from 27965 patients at 67 hospitals, 
PCI performed at hospitals with a volume of >325PCI/year was independently associated with a 
lower hospital mortality (OR = 0.67, 95% CI: 0.52-0.87; p=0.002), although this relationship was 
only significant in cases undertaken for AMI indications and not elective cases 32. Similar 
observations were recorded in the Greater Paris registry, with an association between high centre 
volume and decreased in-hospital mortality reported in emergency cases but not in elective cases 
33. A recent meta-analysis of ten studies comprising 1,322,342 patients in 1746 hospitals 
demonstrated that patients treated in high-volume hospitals (≥600 PCIs/year) experienced 
lower in-hospital mortality (OR=0.87; 95% CI: 0.83 to 0.91) compared to patients treated in 
lower- volume hospitals (400 to 600 PCIs per year) 30. There is some evidence that the 
disparity in outcomes of PCI between high- and low-volume hospitals has narrowed over 
time, for example Ho et al. reported a slight attenuation of the volume–outcome relation for 
PCI, but his finding pertained to the period between 1984 and 1996 with many of the studies 
derived from the pre-stent era, with more contemporary data reporting such temporal changes 
not available 34. Finally, there may be a centre size over which clinical outcomes become 
compromised. For example, a lot of discussion has focussed around the development of high 
volume mega-centre primary PCI programs with potential drawbacks raised that an overload 
of primary PCI patients in such centres may contribute to unintended delays and subsequent 
increases in reperfusion times due to insufficient catheterisation laboratory space, hospital 
beds and operator fatigue 35. In such situations, a negative linear volume outcome relationship 
may offset the linear negative curve into a U shape curve 35. A recent Danish study that 
described the organisation and quality of care after merging two high-volume centres, 
creating one mega centre serving 2.5 million inhabitants, and performing ~1,000 
procedures/year demonstrated that whilst the PPCI for STEMI increased by 102%, door to 
balloon, ECG to balloon and symptom to balloon times decreased significantly and 30 day 
mortality rates remained constant following merger of the two high volume centres 36. Such 
studies provide no evidence for a u-shaped relationship between centre volumes and 
outcomes, mediated through a worsening in outcomes or compromise in quality of care at 
higher volumes. 
 
Discussion:  
 Over the last decade interventional cardiologists, particularly in North America have 
noticed a decline in procedural volume 1, in part through the expansion of the interventional 
cardiology workforce, the number of interventional centres and the greater use of functional / 
ischaemia led revascularisation. Furthermore, with the advent in primary PCI, the 
requirement to run a primary PCI rota has added to the desire to increase operator numbers 
per centre, where there is a balance between safe on-call rotas, and enough PCI activity to 
maintain higher volume operators. These factors have contributed to decrease in operator 
volumes over time that has renewed interest in the relationship between operator volume and 
outcomes. Volume is often used as surrogate for quality measurement as it is easily 
measureable and earlier studies showed correlation of outcomes at both operator and centre 
level. Many of these earlier studies were limited by the definitions of what a high or low 
volume operator constituted, with several of the early studies defining high volume operators 
having undertaken ≥11 procedures per year. Several studies were undertaken in the era before 
stents became routinely used in PCI, hence their ability to inform contemporary practice 
where PCI is undertaken in more complex patients is unclear. Furthermore, studies that have 
focussed on the association between centre volume and outcomes from an institutional 
perspective, have suggested that such relationships may only apply to higher risk cases 
undertaken in the acute situation and not elective cases 32, 33, although it is not known whether 
such associations similarly apply at the level of the individual operator.  
 Some more recent studies seem to suggest that high volume operators outperform low 
volume operators especially in reducing adverse outcomes, although the recent evidence 
regarding hospital-level volume is less clear. ‘Selective referral’ phenomenon may be one 
plausible explanation of the operator-level findings i.e. better performing physicians attract 
more referrals, although it is unlikely that such a phenomenon may influence centre choice in 
the PPCI setting where decisions regarding treatment centre choice are based on locality. The 
studies that have found evidence of a centre-level effect may have more favourable outcomes 
in higher volumes because they simply have better care pathways, more structured and 
streamlined protocols and practice more evidence base treatments which in turn improve 
outcomes 37. For example, in the study by Srinivas et al, higher volume centres were more 
likely to follow evidence-based guidelines 25 whilst Thiemann et al. 38 reported that using 
better care and proven care pathways reduces mortality in patients admitted with AMI in high 
volume centres. It is also important to understand whether working at high volume centres 
have any influence on outcomes at physician level, which may relate to operator skill and 
practice being influenced by their working environment 39.  
 It is important to understand the disparities of operator volume-outcome analyses at 
regional and international level. Geographical variation of PCI volume may explain 
dissimilarities in the volume-outcome relationships reported in the literature, as the definition 
of high volume center in one country may not represent the high volume in another country. 
For instance, the optimal minimum caseload requirements of 400 PCIs per facility were only 
met by 51% of USA centers in 2012 and in fact one third of centers performed less than 200 
PCIs per year 40 whereas in UK only 22% centers had a caseload of less of 400 per year with 
only 2 center performing less than 200 PCIs per . Suchyear  differences in individual volumes 
from both the centre and operator perspective and differences in mortality outcomes across 
different countries may mask any volume-outcome relationships. For example, in countries 
with very high caseload of PCIs at the individual operator / centre and lower mortality rates, 
or conversely in those countries where the vast majority of PCIs are undertaken at low 
volume centres / operators and with higher mortality rates, volume-outcome relationships 
might not be observed. One needs to carefully consider the differences in local PCI practices, 
center and operator volume, geographical variations in PCI related mortality before 
translating these results into local practice. 
 Volume outcome analyses can be used for benchmarking performance both at 
individual operator and centre level, particularly in the move towards national transparency 
agendas in many countries with public reporting of individual operator and centre outcomes. 
Such volume outcomes analyses are useful in assessing quality changes when the delivery of 
services is restructured, with a recent analysis from Denmark demonstrating that doubling the 
capacity of a pPCI centre due to merger of services was feasible without compromising the 
quality of care parameters of in-hospital delays, epicardial reperfusion rate and 30-day 
mortality 36. Such work may help define optimal catchment areas for restructured services, 
and benchmarks to drive quality improvement and clinical outcomes. 
 An important limitation of current data is of lack of evidence on interplay between 
volume-outcome and lifetime experience of operator. In current era, lifetime operator 
experience is an important metrics as senior cardiologists have overseen more than 3 decades 
of advancement of technology and practices in PCI from balloon angioplasty to new 
generation bio absorbable stents. It is perhaps logical to think that lifetime learning and years 
of experience may play an important role in reducing adverse events and complications as 
well as simply the annual volume of operators. To date, lifetime experience has not been 
systematically studied in the PCI setting; however an observational analysis of the UK 
National Cardiac Surgery Audit studying in-hospital mortality in 292,973 CABG procedures 
undertaken by 273 surgeons suggests that crude mortality increased approximately linearly 
until 33 years service 41. Despite adjustment for adverse clinical and procedural 
characteristics and year of surgery, there remained a statistically significant (p=0.002) 
association between length of service and in-hospital mortality (odds ratio 1.013; 95% CI 
1.005-1.021 for each year of 'experience'). This might suggest unmeasured confounding or a 
real association between adverse outcomes and length of service. Finally, as the techniques 
for PCI have become much more standardised, with advancements in stent technology that 
has improved the deliverability and performance of stents, with the development of dedicated 
equipment that enables more complex PCI procedures to be completed more easily, the PCI 
procedure may have become less dependent on the skills of the individual operator and more 
so influenced by advances in technology and equipment. Consequently volume–outcome 
relationships, particularly at the individual operator (or centre) level may be a dynamic 
relationship, which is likely to be particularly evident for new procedures but as the 
procedure becomes more routine, and technological advances become more important such 
relationships will be minimised. Indeed, in support for such a view, some studies have 
reported that the disparity in outcomes of PCI between high- and low-volume hospitals has 
narrowed over time 34. Furthermore, as procedures become more routine, volume outcome 
relationships might only persist for more complex procedures such as CTOs as outlined 
above 27 or in non-elective higher risk cases 33. Consequently for benchmarking and quality 
improvement initiatives, volume outcome relationships may become moving targets, 
inextricably linked with the technological and equipment advances that reduce the 
challenging nature of cases and entry of the procedure being assessed into routine care. 
 
 Conclusion: 
  Both high institutional and operator volumes have been shown to be associated with 
better outcomes by reducing death and in-hospital mortality, although this data is often 
derived from the pre-stent era, or in higher risk patient cohorts. The emphasis of specific 
volume requirement needs to be interpreted with caution, as volume is not a surrogate for 
quality and merely one of the variables associated with outcome. The variation in volume-
outcome relationship between the countries may also make it difficult to translate the results 
into local practice. Health care provider should also focus on other measures such as robust 
clinical care pathways, evidence based treatments, periodic case review, using validated risk 
assessment scores and ascertainment of outcome to improve care and reduce adverse events.  
Furthermore, relative benefits of better outcomes in the context of high volume centres needs 
to carefully weighed against the risks of reducing availability of PCI to wider population.  
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